Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-23-016948

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 15, 2023 42.96M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 $18.22K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$4.86K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $140.08K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $121.86K
Stockholders Equity Q1 2023 · Mar 31, 2023 $20.54K
Stockholders Equity Q1 2023 · Dec 31, 2022 $19.32K
Stockholders Equity Q1 2023 · Mar 31, 2022 $7.08K
Stockholders Equity Q1 2023 · Dec 31, 2021 $38.17K
Total Liabilities Q1 2023 · Mar 31, 2023 $121.91K
Total Liabilities Q1 2023 · Dec 31, 2022 $108.47K
Total Assets Q1 2023 · Mar 31, 2023 $142.45K
Total Assets Q1 2023 · Dec 31, 2022 $127.78K
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2023 $28.78K
Sga Expense Q1 2023 · Mar 31, 2022 $31.09K
Net Income Q1 2023 · Mar 31, 2023 $1.22K
Net Income Q1 2023 · Mar 31, 2022 −$31.09K
Operating Income Q1 2023 · Mar 31, 2023 $1.23K
Operating Income Q1 2023 · Mar 31, 2022 −$31.09K
Revenue Q1 2023 · Mar 31, 2023 $30K